RKDA - Arcadia Biosciences, Inc.
| Previous Close | 5.55 |
| Open | 5.52 |
| Bid | 5.31 x 3100 |
| Ask | 5.34 x 800 |
| Day's Range | 5.25 - 5.54 |
| 52 Week Range | 1.82 - 10.40 |
| Volume | 491,610 |
| Avg. Volume | 3,133,793 |
| Market Cap | 38.022M |
| Beta (3Y Monthly) | -4.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.94 |
| Earnings Date | Aug 14, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
- Benzinga
Cannabis Deals And M&A Picking Up Steam Again
The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions.
- Zacks Small Cap Research
RKDA: Initiating Coverage of RKDA: Leveraging Gene-Editing Expertise to Target High Growth Markets
By Brian Marckx, CFA NASDAQ:RKDA | OTC:VAPNF READ THE FULL RKDA RESEARCH REPORT SNAPSHOT: Anticipating Three Key Launches, Steepening Growth Curve Arcadia Biosciences, Inc (NASDAQ:RKDA) is an innovative agricultural company with a broad and growing product portfolio focused largely on improving the nutritional and other valued-added qualities of crops
- American City Business Journals
Davis ag-tech company raises $9.2 million to pursue growth opportunities
Davis-based crop technology company Arcadia Biosciences Inc. said it raised $9.2 million from a direct offering of its stock to institutional and accredited investors.
- PR Newswire
Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market
DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced the closing of its previously announced registered direct offering of 1,318,828 shares of its common stock. The offering was priced at-the-market at a purchase price per share of $7.52, for gross proceeds of approximately $9.92 million. Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 659,414 shares of common stock, representing 50 percent of the shares of common stock purchased in the registered direct offering.
- Benzinga
The Week In Cannabis: The Vape Craze, Raises Hit $10B, Aurora Cashes In On TGOD, Seth Rogen's Charity Goes Green
On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit. Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana. While many were investing in the cannabis space, Aurora Cannabis Inc. (NYSE: ACB) has started cashing out on some of its investments.
- Benzinga
A Subsidiary Of Arcadia Bio Received A New Hemp License In California
Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA ), announced this week plans for a new sun-grown hemp cultivation and agronomic ...
- PR Newswire
Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market
DAVIS, Calif., Sept. 6, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase of 1,318,828 shares of its common stock, at a purchase price per share of $7.5825, in a registered direct offering priced at-the-market. Additionally, Arcadia has agreed to issue to the investors unregistered warrants to purchase up to 659,414 shares of common stock. The warrants to purchase up to 659,414 shares of common stock have an exercise price of $7.52 per share, will be immediately exercisable, and will expire five and one-half years from the issue date.
- PR Newswire
Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019
DAVIS, Calif. , Sept. 4, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, ...
- Simply Wall St.
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Insiders Increased Their Holdings
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
- GuruFocus.com
Arcadia Biosciences Inc (RKDA) CFO Matthew T Plavan Bought $69,840 of Shares
CFO of Arcadia Biosciences Inc (30-Year Financial, Insider Trades) Matthew T Plavan (insider trades) bought 8,000 shares of RKDA on 08/28/2019 at an average price of $8.73 a share. Continue reading...
- Benzinga
A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Taronis Technologies (NASDAQ: TRNX ) shares ...
- American City Business Journals
Arcadia names new CEO, forecasts big revenue gains; stock soars
Shares of Davis-based Arcadia Biosciences Inc. rose more than 52% on Monday on a large revenue increase forecast by newly named CEO Matthew Plavan.
- MarketWatch
Arcadia stock rockets 35% after company issues bullish guidance for 2020 and 2021
Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, respectively. The company said it expects to begin generating net cash from operations in 2021. Arcadia also announced that Chief Executive Raj Ketkar would retire in September and that the company's board had elected Chief Financial Officer Matthew Plavan as the company's new CEO. Shares of Arcadia have rocketed 174% in the year to date, while the S&P 500 has gained 14.7%.
- Benzinga
Arcadia Biosciences Rallies After Announcing Financial Guidance, Partnerships To Market High-Fiber Wheat
Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for the commercialization of its high-fiber wheat. Bay State Milling will become the exclusive commercial partner for the company’s high-fiber wheat in North America under Bay State Milling’s HealthSense brand portfolio. Arista, on the other hand, will obtain exclusive rights under Arcadia’s intellectual property in Australia, New Zealand, Japan, South Korea and Europe.
- PR Newswire
Arcadia Biosciences Announces Management Succession; Provides Financial Guidance
DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that Raj Ketkar, president and CEO, will retire effective September 1, 2019. In line with its succession plan, the board has appointed Matthew Plavan to chief executive officer and member of the board of directors. Plavan is succeeded by Pam Haley as Arcadia's new chief financial officer.
- PR Newswire
Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat
DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for commercialization of its high fiber resistant starch wheat in key wheat markets, including North America, Europe and parts of Asia.
- Thomson Reuters StreetEvents
Edited Transcript of RKDA earnings conference call or presentation 14-Aug-19 8:30pm GMT
Q2 2019 Arcadia Biosciences Inc Earnings Call
- Benzinga
Former MLB All-Star Shane Victorino Talks Plans To Give Back To Hawaii Through New Cannabis Venture
A few notable names include former Heisman winner Ricky Williams, pro golfer Bubba Watson and NBA great Gary Payton. Former two-time World Series champion Shane Victorino is one of the latest to get involved. Victorino's Hawaii-based venture, Legacy Ventures Hawaii, recently partnered with Arcadia Biosciences (NASDAQ: RKDA) to launch a joint cultivation and extraction venture, Archipelago Ventures.
- CNW Group
Vapen MJ Reports 43% Revenue Increase, 23% Increase in Net Income, for Second Quarter of 2019
Vapen MJ Reports 43% Revenue Increase, 23% Increase in Net Income, for Second Quarter of 2019
- Benzinga
Another Case For Consistent Trading
Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...
- Benzinga
A Look At Benzinga Pro's Most-Searched Tickers For August 15, 2019
This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Pivotal Software (NYSE: PVTL ) shares were ...
- PR Newswire
Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights
Company launches Archipelago™ Ventures, a strategic joint venture for superior hemp production and extraction in Hawaii DAVIS, Calif. , Aug. 14, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: ...
- MarketWatch
Arcadia Biosciences' stock up on heavy volume again, but pulls way back from earlier peak
Shares of Arcadia Biosciences Inc. rose in active trading again on Tuesday, but pulled back sharply from an earlier peak, as the rocket ride of the past two sessions appears ready for a pause. The stock's gains have come after the food ingredients and nutritional oils company's joint venture with Biocerese Crop Solutions Corp. , Verdeca, said last week that its HB4 drought-tolerant soybeans received approval from the U.S. Department of Agriculture. The stock was up 2.2% on volume of of 1.2 million shares ahead of Tuesday's open, but had been up as much as 25.5% earlier in the premarket. The stock had run up 244% over the past two sessions, including a 124.4% rally on volume of 56.7 million shares on Friday and a 53.7% surge on volume of 38.8 million shares on Monday. The stock has now more than doubled year to date through Monday (up 119%), while the S&P 500 has gained 15.0%.
- MarketWatch
Arcadia Biosciences rockets on heavy volume for a 2nd straight day
Shares of Arcadia Biosciences Inc. rocketed higher again Monday, running up 53% on heavy volume after jetting 124% higher the previous session, to pace the Nasdaq exchanges gainers. Trading volume was 25.4 million shares, compared with the full-day average of about 2 million shares, and after turning over 56.7 million shares on Friday. The stock more than doubled on Friday after Verdeca, a joint venture between Arcadia and Bioceres Crop Solutions Corp. said its HB4 drought-tolerant soybeans received approval from the U.S. Department of Agriculture. Arcadia's stock has now gained 15.6% over the past 12 months, while the iShares Nasdaq Biotechnology ETF has lost 10.2% and the S&P 500 has edged up 2.2%. Arcadia's stock was back up toward levels last seen during the February-March rally, which was on the back of the company's announcement of a cannabis-focused business unit.
- American City Business Journals
Davis biotech company shares soar following USDA approval
Shares in Davis-based Arcadia Biosciences Inc. shot up 124% Friday on news of a USDA approval for drought-tolerant soybeans the company has developed in a joint partnership with Bioceres Crop Solutions Corp.
